AGIOS PHARMACEUTICALS, INC. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Agios Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2023.
  • Agios Pharmaceuticals, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $380M, a 28.3% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $380M +$83.7M +28.3% Dec 31, 2023 10-K 2024-02-15
Q4 2022 $296M +$59.5M +25.2% Dec 31, 2022 10-K 2024-02-15
Q4 2021 $236M -$358M -60.2% Dec 31, 2021 10-K 2024-02-15
Q4 2020 $595M +$92.5M +18.4% Dec 31, 2020 10-K 2023-02-23
Q4 2019 $502M +$111M +28.5% Dec 31, 2019 10-K 2022-02-24
Q4 2018 $391M +$88.8M +29.4% Dec 31, 2018 10-K 2021-02-25
Q4 2017 $302M +$93.9M +45.1% Dec 31, 2017 10-K 2019-02-14
Q4 2016 $208M +$86.2M +70.7% Dec 31, 2016 10-K 2018-02-14
Q4 2015 $122M +$52.4M +75.5% Dec 31, 2015 10-K 2017-02-16
Q4 2014 $69.4M +$22.9M +49.2% Dec 31, 2014 10-K 2016-02-26
Q4 2013 $46.5M +$14.8M +46.4% Dec 31, 2013 10-K 2015-02-24
Q4 2012 $31.8M +$21.1M +197% Dec 31, 2012 10-K 2014-03-18
Q4 2011 $10.7M Dec 31, 2011 10-K 2016-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.